Drugplain

Azelastine Hydrochloride .5 mg/mL

azelastine hydrochloride · SOLUTION/ DROPS · Sandoz Inc

4 Recalls on RecordCurrently in Shortage
Plain English

Azelastine Hydrochloride is a solution/ drops containing azelastine hydrochloride at .5 mg/mL, taken intraocular. Manufactured by Sandoz Inc.

Key Facts

Brand Name
Azelastine Hydrochloride
Generic Name
azelastine hydrochloride
NDC Code (Product)
61314-308
Manufacturer
Sandoz Inc
Strength
.5 mg/mL
Dosage Form
SOLUTION/ DROPS
Route
INTRAOCULAR
Marketing Status
Application #
ANDA202305
Marketing Start
03/21/2013

Recall History

4 Recalls on Record
Class II04/26/2023

Akorn, Inc.

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

OngoingVoluntary: Firm initiated
Class II02/01/2019

Mylan Pharmaceuticals Inc.

Defective Container: Potential for broken glass in the neck area of the glass bottles.

TerminatedVoluntary: Firm initiated
Class II07/25/2018

Mylan Pharmaceuticals Inc.

Presence of foreign substance: Potential for glass in the neck area of the glass bottles.

TerminatedVoluntary: Firm initiated
Class III12/14/2016

Roxane Laboratories, Inc.

Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

treatment failure1,877 reports
drug ineffective1,154 reports
fatigue1,111 reports
product dose omission issue932 reports
headache860 reports
nausea848 reports
dyspnoea826 reports
pain741 reports
cough720 reports
diarrhoea718 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE Azelastine hydrochloride nasal spray is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. Azelastine hydrochloride nasal spray is an H1-receptor antagonist indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. ( 1 )

Dosage & Administration

2 DOSAGE AND ADMINISTRATION For intranasal use only ( 2.3 ) Seasonal allergic rhinitis: Pediatric patients 5 to 11 years of age: 1 spray per nostril twice daily ( 2.1 ) Adults and adolescents 12 years of age and older: 1 or 2 sprays per nostril twice daily ( 2.1 ) Vasomotor rhinitis: 2 sprays per nostril twice daily in adults and adolescents 12 years of age and older ( 2.2 ) Prime azelastine hydrochloride nasal spray before initial use and when it has not been used for 3 or more days ( 2.3 ) 2.1 Seasonal Allergic Rhinitis The recommended dosage of azelastine hydrochloride nasal spray in adults and adolescent patients 12 years and older with seasonal allergic rhinitis is one or two sprays per nostril twice daily. The recommended dosage of azelastine hydrochloride nasal spray in pediatric patients 5 years to 11 years of age is one spray per nostril twice daily. 2.2 Vasomotor Rhinitis The recommended dosage of azelastine hydrochloride nasal spray in adults and adolescent patients 12 years and older with vasomotor rhinitis is two sprays per nostril twice daily. 2.3 Important Administration Instructions Administer azelastine hydrochloride nasal spray by the intranasal route only. Primin

Contraindications

4 CONTRAINDICATIONS None. None ( 4 )

Drug Interactions

7 DRUG INTERACTIONS 7.1 Central Nervous System Depressants Concurrent use of azelastine hydrochloride nasal spray with alcohol or other central nervous system depressants should be avoided because reductions in alertness and impairment of central nervous system performance may occur [see Warnings and Precautions ( 5.1 )].

Adverse Reactions

6 ADVERSE REACTIONS Use of azelastine hydrochloride nasal spray has been associated with somnolence [see Warnings and Precautions ( 5.1 )]. The most common adverse reactions (≥2% incidence) are: bitter taste, headache, somnolence, dysesthesia, rhinitis, nasal burning, pharyngitis, epistaxis, sinusitis, paroxysmal sneezing, nausea, dry mouth, fatigue, dizziness, and weight increase. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Apotex CORP. at 1-800-706-5575 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect rates observed in practice. Seasonal Allergic Rhinitis Azelastine hydrochloride nasal spray Two Sprays Per Nostril Twice Daily Adverse experience information for azelastine hydrochloride nasal spray is derived from six placebo- and active- controlled, 2-day to 8-week clinical trials which included 391 patients, 12 years of age and older, with seasonal allergic rhinitis who received azelastine hydrochloride nasal spray

Frequently Asked Questions

What is Azelastine Hydrochloride used for?

Azelastine Hydrochloride contains azelastine hydrochloride. It is a solution/ drops taken intraocular. Consult your doctor for specific uses.

Is Azelastine Hydrochloride a controlled substance?

Azelastine Hydrochloride is not classified as a controlled substance by the DEA.

What is the generic name for Azelastine Hydrochloride?

The generic name for Azelastine Hydrochloride is azelastine hydrochloride. There are 6 other brand versions of azelastine hydrochloride.

What is the NDC code for Azelastine Hydrochloride .5 mg/mL?

The NDC (National Drug Code) for Azelastine Hydrochloride .5 mg/mL is 61314-308, listed by Sandoz Inc.